Aadi Bioscience, Inc. (AADI) Misses Q2 EPS by 12c

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q2 EPS of ($0.87), $0.12 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $3.4 million versus the consensus estimate of $2.75 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform